On a frosty morning last month in a Minneapolis suburb, Abigail Hansmeyer left her car engine running and took out a brown paper bag carrying needles and a vial, handing it over to its recipient in an anonymous shopping center parking lot.
The exchange is technically illegal, but these are not illicit drugs. Instead, the vial contains insulin: A medicine that has since its discovery in the 1920s transformed a diagnosis of diabetes from a swift death sentence to a manageable disease.
Yet, its price has skyrocketed in the US over the past decade, creating informal networks of people who build up stockpiles and give to others what they do not need themselves.
Photo: AFP
“Thank you so much,” 52-year-old Annette Gentile said as she took the bag from Hansmeyer, checking the labels and doses.
“I’ve been on a roller coaster in the last few days,” she added, because of her elevated blood sugar levels.
Gentile does not live in abject poverty. She receives a monthly disability allowance of US$1,200 and has public health insurance.
However, crucially, that insurance does not cover prescription medicine.
The contents of the bag she just received, which will keep her going for a month, would cost her about US$1,000 at a pharmacy.
“I purely rely on donations,” she said.
Her benefactor, 29-year-old Hansmeyer, is unemployed and has type 1 diabetes, a chronic condition that appears in childhood in which the pancreas produces little or no insulin, the hormone that lets sugar enter cells to produce energy.
People who have it need to inject themselves with insulin several times each day for the rest of their lives.
Both women are part of a group of diabetics who connect with each over Facebook or text messages to hand out or receive their prized medication, free of cost, sometimes using code words like “lifewater” to evade detection.
Nearly all of the stock that circulates comes from the relatives of patients who died.
For US President Donald Trump’s rivals in the Democratic Party, who tomorrow begin their primary contests in Iowa, there are few scandals greater than the price of insulin: The epitome of pharmaceutical price-gouging that blights the US healthcare system.
“We’re not poor,” Hansmeyer said.
Her husband works and has started a small business, she has her own car and the couple live in a house that pet dogs and rabbits also call home.
However, her husband’s employer does not subsidize its workers health insurance. Not poor enough to qualify for state insurance and not rich enough to buy their own, the couple gave up looking last month.
They joined the ranks of the 27.5 million Americans without coverage, praying that no calamity befalls them.
“My entire adult life I’ve gone in and out of rationing my insulin,” Hansmeyer told reporters.
She said that she remembers crying with happiness a few years ago, when she won a battle against her then insurer for an insulin pump, a computerized device that continuously releases the right amount of the hormone.
Hansmeyer acts as a go-between for her community of Minneapolis-area diabetics, connecting those in need with those who have. One of her major sources is a refrigerator in the basement of a house belonging to Nicole Smith-Holt.
Smith-Holt opened its door to reveal a treasure trove: Dozens of vials of insulin and a large stock of syringes, test strips and other supplies. She guessed its value at about US$50,000.
“It is strictly illegal,” she said.
Selling or even giving away prescription medicine is technically a minor crime, but for Smith-Holt, it is a cause that is devastatingly close to her heart.
“We don’t need another Alec,” she said, referring to her son who died in June 2017.
Alec Raeshawn Smith was covered by his mother’s insurance until he turned 26, the age up to which insurers are obliged under a law enacted by former US president Barack Obama to allow adult children to remain covered by their parent’s plans.
After crossing that threshold, he found himself unable to afford his own insurance on his meager salary as a restaurant worker. He died 27 days after his insurance lapsed from diabetic ketoacidosis as a result of a lack of insulin.
There was not a drop of insulin to be found in his apartment, Smith-Holt said, but added that there was evidence her son had tampered with his insulin pens to try to squeeze out every last bit.
“I think until I take my last breath I’ll feel a sense of guilt in some sort of way,” Smith-Holt said. “I wish he would have asked for help.”
The death of her son, who was himself a father, transformed Smith-Holt into an activist. One day she is on TV, the next she is lobbying local politicians, or protesting outside a pharmaceutical company.
Further to the north, diabetics can look to providers on the right side of the law, but the wrong side of the border: Canadian pharmacies.
Unlike the US, Canada caps the price of insulin. Every three months, alone or with others, 47-year-old Travis Paulson makes the two-hour drive from Eveleth in northern Minnesota to Fort Frances in Canada’s Ontario Province, crossing the Rainy River to buy his insulin without prescription.
Customs agents do not bother him as long as his supply is less than three months’ worth.
His insurance is excellent as far as doctor visits go, but only pays half the price of medicines.
He pulled out two almost identical vials of insulin: one is labeled NovoLog and costs US$345 in the US, with his insurance leaving him responsible for half the bill.
The Canadian vial is sold under the brand name NovoRapid and costs about US$25. The math is not hard.
“It’s pharmaceutical greed. It’s greed is all it is, simple as that,” he said.
A sticker for US Senator Bernie Sanders on his fridge shows off Paulson’s support for the self-professed democratic socialist, who has vowed to cut drug costs in half.
However, even that might not be enough to reduce the appeal of his Canadian road trips.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day